A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis

被引:21
作者
Piao, Jin [1 ]
Lafin, John T. [2 ]
Scarpini, Cinzia G. [3 ]
Nuno, Michelle M. [1 ]
Syring, Isabella [4 ]
Dieckmann, Klaus-Peter [5 ]
Belge, Gazanfer [6 ]
Ellinger, Joerg [4 ]
Amatruda, James F. [7 ,8 ]
Bagrodia, Aditya
Coleman, Nicholas [3 ,9 ]
Krailo, Mark D. [1 ]
Frazier, A. Lindsay [10 ]
Murray, Matthew J. [3 ,11 ]
机构
[1] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA USA
[2] Univ Texas Southwestern Med Ctr, Dept Urol, Dallas, TX USA
[3] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England
[4] Univ Bonn, Dept Urol, Bonn, Germany
[5] Asklepios Klin Altona, Dept Urol, Hamburg, Germany
[6] Univ Bremen, Fac Biol & Chem, Bremen, Germany
[7] Childrens Hosp Los Angeles, Canc & Blood Dis Inst, Los Angeles, CA USA
[8] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[9] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England
[10] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA USA
[11] Cambridge Univ Hosp NHS Fdn Trust, Dept Paediat Haematol & Oncol, Cambridge, England
关键词
Biomarker; germ; microRNA; testis cancer; SERUM; MICRORNAS; BIOMARKERS; MARKERS;
D O I
10.1016/j.clgc.2021.08.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circulating microRNA testing is likely to transform future management for testicular cancer patients. Here, we undertook a pooled analysis (329 patients) to test whether measurement of a single microRNA is sufficient for detecting testicular cancer, or whether it is necessary to quantify other members of the four microRNA panel previously identified (miR-371a-3p/miR-372-3p/miR-373-3p/miR-367-3p). We show that quantifying circulating miR-371a-3p alone is sufficient for testicular cancer diagnosis. Background: Circulating microRNAs have clear potential for improving malignant germ-cell-tumor (MGCT) diagnosis. Here, we address the central issue of whether measurement of a single microRNA is sufficient for detecting testicular MGCTs, or whether there is added benefit in quantifying other members of the 4-microRNA panel previously identified (miR-371a-3p/miR-372-3p/miR-373-3p and miR-367-3p). Patients and Methods: We performed a pooled analysis of available published raw data where all 4 panel miRNAs had been assessed using pre-amplification PCR technology (4 studies; total 329 patients). Two studies using identical methodology (and identical normalization using endogenous miR-30b-5p) were used in the discovery phase (n = 51 patients: 17 MGCT, 34 controls). The 2 other studies (n = 278 patients: 140 MGCT, 138 controls), which assessed the same test panel but with different normalization approaches (endogenous miR-93-5p, exogenous cel-miR-39-3p), were used for the validation phase. We derived sensitivity, specificity, positive- and negative-predictive-values (PPV/NPV) for the detection thresholds that maximised the Youden Index (YI). Results: In the discovery-phase, the YI was 0.97 for miR-371a-3p (sensitivity = 1, specificity = 0.97), 0.71 (miR367-3p), 0.68 (miR-372-3p), and 0.50 (miR-373-3p). These findings were confirmed in the validation-phase, with YI of 0.75 for miR-371a-3p (sensitivity = 0.90, specificity 0.85), 0.55 (miR-367-3p), 0.47 (miR-372-3p), and 0.51 (miR373-3p). Importantly, no combination of markers added additional diagnostic benefit to miR-371a-3p alone, in either the discovery or the validation phase. Conclusion: Quantifying circulating miR-371a-3p alone is sufficient for testicular MGCT diagnosis. PCR measurement of this single miRNA marker will be more cost-effective and easier to interpret, facilitating future incorporation into routine clinical practice. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:469 / 479
页数:11
相关论文
共 23 条
  • [1] Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours
    Almstrup, Kristian
    Lobo, Joao
    Morup, Nina
    Belge, Gazanfer
    Rajpert-De Meyts, Ewa
    Looijenga, Leendert H. J.
    Dieckmann, Klaus-Peter
    [J]. NATURE REVIEWS UROLOGY, 2020, 17 (04) : 201 - 213
  • [2] Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumours
    Bagrodia, Aditya
    Savelyeva, Anna
    Lafin, John T.
    Speir, Ryan W.
    Chesnut, Gregory T.
    Frazier, Anne Lindsay
    Woldu, Solomon L.
    Margulis, Vitaly
    Murray, Matthew J.
    Amatruda, James F.
    Lotan, Yair
    [J]. BJU INTERNATIONAL, 2021, 128 (01) : 57 - 64
  • [3] Cost Analysis of Noninvasive Blood-Based MicroRNA Testing Versus CT Scans for Follow-up in Patients With Testicular Germ-Cell Tumors
    Charytonowicz, Daniel
    Aubrey, Harry
    Bell, Chantelle
    Ferret, Maeline
    Tsui, Keith
    Atfield, Rachel
    Coleman, Nicholas
    Murray, Matthew J.
    Wilson, Edward C. F.
    [J]. CLINICAL GENITOURINARY CANCER, 2019, 17 (04) : E733 - E744
  • [4] Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
    Dieckmann, Klaus-Peter
    Radtke, Arlo
    Geczi, Lajos
    Matthies, Cord
    Anheuser, Petra
    Eckardt, Ulrike
    Sommer, Joerg
    Zengerling, Friedemann
    Trenti, Emanuela
    Pichler, Renate
    Belz, Hanjo
    Zastrow, Stefan
    Winter, Alexander
    Melchior, Sebastian
    Hammel, Johannes
    Kranz, Jennifer
    Bolten, Marius
    Krege, Susanne
    Haben, Bjoern
    Loidl, Wolfgang
    Ruf, Christian Guido
    Heinzelbecker, Julia
    Heidenreich, Axel
    Cremers, Jann Frederik
    Oing, Christoph
    Hermanns, Thomas
    Fankhauser, Christian Daniel
    Gillessen, Silke
    Reichegger, Hermann
    Cathomas, Richard
    Pichler, Martin
    Hentrich, Marcus
    Eredics, Klaus
    Lorch, Anja
    Wuelfing, Christian
    Peine, Sven
    Wosniok, Werner
    Bokemeyer, Carsten
    Belge, Gazanfer
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (16) : 1412 - +
  • [5] Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours
    Dieckmann, Klaus-Peter
    Radtke, Arlo
    Spiekermann, Meike
    Balks, Thomas
    Matthies, Cord
    Becker, Pascal
    Ruf, Christian
    Oing, Christoph
    Oechsle, Karin
    Bokemeyer, Carsten
    Hammel, Johannes
    Melchior, Sebastian
    Wosniok, Werner
    Belge, Gazanfer
    [J]. EUROPEAN UROLOGY, 2017, 71 (02) : 213 - 220
  • [6] Pre-Implementation Assessment of the Acceptability of Using Circulating microRNAs for Follow-Up of Malignant Germ-Cell Tumors
    Fern, Lorna A.
    Greenwood, Michelle
    Smith, Shievon
    Brand, Susan
    Coleman, Nicholas
    Stark, Daniel P.
    Murray, Matthew J.
    [J]. CLINICAL GENITOURINARY CANCER, 2021, 19 (05) : 381 - 387
  • [7] American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors
    Gilligan, Timothy D.
    Seidenfeld, Jerome
    Basch, Ethan M.
    Einhorn, Lawrence H.
    Fancher, Timothy
    Smith, David C.
    Stephenson, Andrew J.
    Vaughn, David J.
    Cosby, Roxanne
    Hayes, Daniel F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3388 - 3404
  • [8] Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle
    Gillis, Ad J. M.
    Rijlaarsdam, Martin A.
    Eini, Ronak
    Dorssers, Lambert C. J.
    Biermann, Katharina
    Murray, Matthew J.
    Nicholson, James C.
    Coleman, Nicholas
    Dieckmann, Klaus-Peter
    Belge, Gazanfer
    Bullerdiek, Joern
    Xu, Tom
    Bernard, Nathalie
    Looijeng, Leendert H. J.
    [J]. MOLECULAR ONCOLOGY, 2013, 7 (06) : 1083 - 1092
  • [9] Absolute quantification by droplet digital PCR versus analog real-time PCR
    Hindson, Christopher M.
    Chevillet, John R.
    Briggs, Hilary A.
    Gallichotte, Emily N.
    Ruf, Ingrid K.
    Hindson, Benjamin J.
    Vessella, Robert L.
    Tewari, Muneesh
    [J]. NATURE METHODS, 2013, 10 (10) : 1003 - +
  • [10] Genetic polymorphisms in DNA repair genes XRCC1 and 3 are associated with increased risk of breast cancer in Bangladeshi population
    Howlader, Nupur Rani
    Rahman, Md. Mostafizur
    Hossain, Md. Amir
    Sultana, Razia
    Hossain, Syed Mozammel
    Mazid, Md. Abdul
    Rahman, Md. Mustafizur
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (03) : 739 - 750